Skip to main content
Clinical Trials/NCT06008301
NCT06008301WithdrawnNot Applicable

Comparing Impact of Contrast-enhanced Mammography (CEM) to Breast MRI on Barriers to Breast Cancer Treatment

Boston Medical Center0 sites60 target enrollmentStarted: April 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
60
Primary Endpoint
Patient financial costs

Study Overview

Brief Summary

The investigators will study the financial, time, and psychologic benefit of Contrast Enhanced Mammography (CEM) compared with Magnetic Resonance Imaging (MRI) for breast cancer evaluation and ultimately encourage practices and referring providers to use it more routinely in practice.

Specific research objectives are to:

  • determine financial costs of performing a CEM to breast MRI
  • compare time costs involved with CEM to breast MRI
  • compare psychologic costs involved with CEM to breast MRI.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
30 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > or equal to 30 years
  • Clinically eligible for CEM or breast MRI
  • Newly diagnosed cancer

Exclusion Criteria

  • Pregnant as verified by patient report. Given that this test is being performed for clinical purposes, the determination of pregnancy status will be resolved via the standard clinical pathway.

Outcomes

Primary Outcomes

Patient financial costs

Time Frame: 24 months

Patient costs will be determined by capturing insurance coverage and hospital-provided patient charges.

Institutional financial costs

Time Frame: 24 months

True institutional costs will be calculated using time-driven activity based costing (TDABC) methodology to estimate the capacity cost rate (CCR, defined as cost per unit time in dollars per minute for personnel, equipment, and fixed equipment) and total cost (TC, defined as the sum of CCR per resource multiplied by time utilization and added to cost of consumable materials) for MRI and CEM.

Time from diagnosis to first treatment

Time Frame: 24 months

Time will be measured in days and abstracted from medical records.

Time from diagnosis to imaging modality (CEM or MRI)

Time Frame: 24 months

Time will be measured in days and abstracted from medical records.

Number of patient visits generated from the imaging modality

Time Frame: 24 months

Number of patient visits generated from the imaging modality will be abstracted from medical records.

Psychologic costs to patients

Time Frame: 24 months

The State-Trait Anxiety Inventory (STAI) has 20 items for assessing trait anxiety and 20 for state anxiety. All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials